Jingzang Tao Miu
Publications by Year
Research Areas
Immunotherapy and Immune Responses, CAR-T cell therapy research, PARP inhibition in cancer therapy, Cancer Research and Treatments, Sarcoma Diagnosis and Treatment
Most-Cited Works
- → E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling(2015)84 cited
- → Abstract 4698: ONCR-1, a novel herpes simplex virus expressing MMP9 and ULBP3 transgenes, evokes potent oncolysis and development of antitumor immune responses(2018)1 cited
- → 1387 SNT-20109 induces protective immunity in the murine syngeneic tumor cell line, CT26: a dual approach of direct cytotoxicity and defined immune activation(2023)
- → Abstract 2733: Antitumor activity of the PARP inhibitor E7449 in Ewing's sarcoma(2014)
- → 1403-B Sonata’s proprietary intrinsic antigen release technology (iART) drives in situ generation of potent anti-tumor immunity across warm and cold tumor models(2023)